20260805_160021.jpg
Check and provide each and everything
analyse_media
Reading File
Here is the complete, organized breakdown of everything on this prescription sheet:
Patient Details
| Field | Info |
|---|---|
| Name | B. Vijay Laxmi, Bhupal |
| Gender | Female |
| Age | 50 years old |
Diagnoses (D/s)
- AFI - Acute Febrile Illness
- LKT I - Likely refers to Left Kidney / or a related diagnosis (context-dependent)
- OAD - Obstructive Airway Disease
- Pulmonary Fibrosis (Bilateral lung fibrosis - noted as "B/L lung fibrosis")
Vitals / On Examination (O/E)
| Parameter | Value |
|---|---|
| Patient State | Conscious, oriented (C/C) |
| Temperature | 99.6°F |
| BP (Blood Pressure) | 140/100 mmHg |
| PR (Pulse Rate) | 104/min |
| SpO2 | 97% (written as CPO2 or SpO2) |
Co-morbidities / Background
- K/C/O (Known Case Of): Renovascular HTN (Hypertension)
- C/O: General weakness + Anemia (written as "Anaemia" / "General weakness")
Drug Prescription
Syrups
| # | Drug | Dose | Route | Frequency |
|---|---|---|---|---|
| 1 | Syp. Pulmolear (Ambroxol / mucolytic combo) | 5 ml | P/O | Twice daily |
| 2 | Syp. Zincovit | 5 ml | P/O | Once daily |
| 3 | Syp. Muconget | 10 ml | P/O | Twice daily (STOP noted) |
Tablets
| # | Drug | Dose | Route | Frequency | Notes |
|---|---|---|---|---|---|
| 1 | Tab. Pantop (Pantoprazole) | 40 mg | P/O | Once daily | |
| 2 | Tab. CINOD (Cinnarizine + Domperidone) | 10 mg | P/O | Twice daily | STOP noted |
| 3 | Tab. Mirago (Mirtazapine) | 25 mg | P/O | Once daily | |
| 4 | Tab. Librax (Chlordiazepoxide + Clidinium) | 1 tab (15 mg) | P/O | Once daily | |
| 5 | Tab. Mini Pren (Minipress / Prazosin) | 5 ml / 8/10 mg | P/O | Once daily | STOP noted (crossed out) |
| 6 | Tab. Nebistar (Nebivolol) | 1 mg | P/O | Once daily |
Nebulization
| # | Drug | Dose | Route | Frequency |
|---|---|---|---|---|
| 1 | Neb. Nebzmart (likely Levosalbutamol + Ipratropium) | 1 amp | P/O (via nebulizer) | Thrice daily |
Special Instructions
- 7. Quino hike - Likely Quinolone antibiotic (e.g., Levofloxacin/Ofloxacin) - OD x 10 days (Once daily for 10 days)
- (STOP) noted against Tab. CINOD, Syp. Muconget, and Tab. Mini Pren - these drugs have been discontinued/crossed out
Summary of Clinical Picture
This is a 50-year-old female with:
- Acute febrile illness being treated with a quinolone antibiotic for 10 days
- Bilateral pulmonary fibrosis + OAD managed with nebulization (Nebzmart), mucolytic syrup (Pulmolear)
- Renovascular hypertension managed with Nebivolol (Beta-blocker); Minipress/Prazosin was previously prescribed but STOPPED
- Anemia being addressed with Zincovit (zinc + vitamins)
- GI protection via Pantoprazole
- Mirtazapine (Mirago 25 mg) suggests appetite stimulation or mild depression/anxiety
- Librax for GI spasm / anxiety
- Some drugs (CINOD, Muconget, Mini Pren) have been marked STOP, indicating they were previously on the regimen and now discontinued
Note: Some handwriting was partially illegible; interpretations above are based on context and common drug names used in Indian clinical practice. Always verify with the prescribing physician before dispensing.
17859265676265548326154288954124.jpg
17859265879361112566294630031378.jpg
Read the case and check the moa adrs side effects drug drug interaction prescription reconciliation
analyse_media
analyse_media
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Searching the Web
drug interactions mirtazapine nebivolol levofloxacin QT prolongation chlordiazepoxide
Here is the complete clinical pharmacology review for this prescription:
CLINICAL PHARMACOLOGY REVIEW
Patient: B. Vijay Laxmi | Female | 50 years
Diagnoses: AFI, LRTI, OAD, Bilateral Pulmonary Fibrosis
K/C/O: Hypertension (Renovascular), Anemia
Vitals: Temp 99.6°F | BP 140/100 mmHg | PR 104/min | SpO2 97%
COMPLETE DRUG LIST (Active Prescription)
| # | Drug (Brand) | Generic | Dose | Route | Frequency |
|---|---|---|---|---|---|
| 1 | Syp. Pulmoclear | Ambroxol + Guaifenesin | 5 ml | PO | BD |
| 2 | Syp. Zincovit | Zinc + Multivitamins | 5 ml | PO | OD |
| 3 | Syp. Muconget | Acetylcysteine/Carbocisteine | 10 ml | PO | BD |
| 4 | Tab. Pantop | Pantoprazole | 40 mg | PO | OD |
| 5 | Tab. CINOD | Cinnarizine + Domperidone | 10 mg | PO | BD |
| 6 | Tab. Mirago | Mirtazapine | 25 mg (likely 7.5/15 mg) | PO | OD |
| 7 | Tab. Librax | Chlordiazepoxide 5 mg + Clidinium 2.5 mg | 1 tab | PO | OD |
| 8 | Tab. Nebistar | Nebivolol | 5 mg | PO | OD |
| 9 | Neb. Nebzmart | Levosalbutamol + Ipratropium | 1 amp | Nebulization | TID |
| 10 | Tab. Quinohike | Levofloxacin 500 mg | 1 tab | PO | OD x 10 days |
| - |
SECTION 1: MECHANISM OF ACTION (MOA)
1. Syp. Pulmoclear (Ambroxol + Guaifenesin)
MOA:
- Ambroxol: Mucokinetic agent. Stimulates surfactant production by type II pneumocytes, reduces sputum viscosity by breaking disulfide bonds in mucus glycoproteins, increases ciliary beat frequency, and promotes mucociliary clearance.
- Guaifenesin: Expectorant. Increases respiratory tract fluid secretion, hydrates mucus, reduces adhesiveness, making it easier to expectorate.
2. Syp. Muconget (Acetylcysteine / N-acetylcysteine)
MOA: Mucolytic. Breaks disulfide (-S-S-) bonds in mucus glycoproteins via its free sulfhydryl (-SH) group, directly reducing the viscosity and elasticity of mucus. Also acts as an antioxidant (glutathione precursor), which may benefit in pulmonary fibrosis.
3. Syp. Zincovit (Zinc + B-vitamins + Vitamin C)
MOA: Zinc is a cofactor for >300 enzymatic reactions, essential for immune function, erythropoiesis, and wound healing. B-vitamins (B12, folic acid, B6) are required for red blood cell maturation - important here for anemia.
4. Tab. Pantoprazole (Pantop 40 mg)
MOA: Irreversible proton pump inhibitor (PPI). Covalently binds and inhibits H+/K+-ATPase (the proton pump) on the luminal surface of gastric parietal cells. This blocks the final step of acid secretion, reducing gastric acid output by up to 98%.
5. Tab. CINOD (Cinnarizine + Domperidone)
MOA:
- Cinnarizine: Calcium channel blocker (vascular) + H1 antihistamine. Blocks Ca2+ entry in smooth muscle, causes cerebral vasodilation, reduces vestibular excitability - used for vertigo/nausea.
- Domperidone: Dopamine D2 receptor antagonist (peripheral). Acts on the chemoreceptor trigger zone (CTZ) and gastric wall - prokinetic and antiemetic. Does NOT cross BBB significantly.
6. Tab. Mirago (Mirtazapine 25 mg)
MOA (NaSSA - Noradrenergic and Specific Serotonergic Antidepressant):
- Blocks presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors → increases release of both norepinephrine (NE) and serotonin (5-HT)
- Simultaneously blocks 5-HT2A, 5-HT2C, and 5-HT3 receptors → channels serotonin selectively through 5-HT1A receptors, reducing nausea and sexual side effects
- Strong H1 histamine blockade → sedation and appetite stimulation (useful here for anorexia/weakness)
- (Source: Stahl's Essential Psychopharmacology)
7. Tab. Librax (Chlordiazepoxide 5 mg + Clidinium 2.5 mg)
MOA:
- Chlordiazepoxide: Benzodiazepine. Positive allosteric modulator at GABA-A receptors → increases frequency of Cl- channel opening → hyperpolarization → anxiolytic, muscle relaxant.
- Clidinium: Anticholinergic (muscarinic antagonist) → reduces GI smooth muscle spasm, decreases gastric acid secretion.
- Combination used for anxiety with GI spasm (irritable bowel-type symptoms).
8. Tab. Nebistar (Nebivolol 5 mg)
MOA: Third-generation beta-1 selective adrenoceptor blocker + stimulates beta-3 receptors → increases NO (nitric oxide) production via endothelial eNOS → vasodilation. Results in reduced heart rate, reduced cardiac output, and vasodilation. Has metabolically neutral profile compared to older beta-blockers.
9. Neb. Nebzmart (Levosalbutamol + Ipratropium)
MOA:
- Levosalbutamol: Beta-2 adrenergic agonist → activates adenylyl cyclase → increases cAMP → relaxes bronchial smooth muscle → bronchodilation. R-enantiomer of salbutamol (fewer cardiac side effects than racemic mix).
- Ipratropium: Muscarinic (M3) antagonist → blocks ACh-mediated bronchoconstriction → bronchodilation, reduces secretions. Particularly useful in OAD/COPD.
10. Tab. Quinohike (Levofloxacin 500 mg)
MOA: Fluoroquinolone antibiotic. Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV → prevents DNA supercoil relaxation and chromosomal separation during replication → bactericidal effect. Broad spectrum coverage including atypical organisms (Mycoplasma, Legionella) - appropriate for LRTI.
SECTION 2: ADVERSE DRUG REACTIONS (ADRs) & SIDE EFFECTS
| Drug | Common Side Effects | Serious ADRs |
|---|---|---|
| Ambroxol/Guaifenesin | Nausea, diarrhea, gastric discomfort | Rare: allergic reactions, Stevens-Johnson syndrome |
| Acetylcysteine (Muconget) | Nausea, vomiting, stomatitis, unpleasant smell | Bronchospasm (inhaled form), rare anaphylaxis |
| Zincovit | GI upset if taken on empty stomach | Zinc toxicity with long-term overuse |
| Pantoprazole | Headache, diarrhea, flatulence, nausea | Hypomagnesemia (long-term), C. diff risk, osteoporosis (chronic use), vitamin B12 deficiency |
| Cinnarizine/Domperidone | Drowsiness (cin), dry mouth, headache | Domperidone: QT prolongation (cardiac risk!), tardive dyskinesia (long-term), elevated prolactin |
| Mirtazapine | Weight gain, sedation, increased appetite, dry mouth | QT prolongation (mild), serotonin syndrome (with other serotoninergic drugs), hyponatremia |
| Librax (Chlordiazepoxide + Clidinium) | Drowsiness, dry mouth, blurred vision, urinary retention | Dependence/withdrawal, paradoxical excitation; clidinium: urinary retention, constipation, glaucoma aggravation |
| Nebivolol | Fatigue, bradycardia, cold extremities, dizziness | Bronchospasm (in asthmatics/OAD!), hypoglycemia masking, rebound hypertension on abrupt withdrawal |
| Levosalbutamol + Ipratropium | Tremor, palpitations (levosalb), dry mouth (ipatropium), tachycardia | Hypokalemia (levosalbutamol), paradoxical bronchospasm, urinary retention (ipatropium in elderly) |
| Levofloxacin | GI upset, headache, insomnia, dizziness | QT prolongation, tendinopathy/tendon rupture, peripheral neuropathy, C. diff colitis, photo-sensitization |
SECTION 3: DRUG-DRUG INTERACTIONS (DDIs)
🔴 MAJOR / CLINICALLY SIGNIFICANT
| Interaction | Drugs Involved | Risk | Mechanism |
|---|---|---|---|
| QT Prolongation (Additive) | Levofloxacin + Domperidone + Mirtazapine | HIGH - risk of Torsades de Pointes, ventricular arrhythmia | All three independently prolong QT interval. Triple combination is dangerous, especially with tachycardia (PR 104) already present. |
| CNS Depression (Additive) | Mirtazapine + Chlordiazepoxide (Librax) | MODERATE-HIGH | Both cause CNS sedation - additive depression, excessive sedation, respiratory depression risk |
| Anticholinergic burden | Clidinium (Librax) + Ipratropium (Nebzmart) | MODERATE | Both are anticholinergics - additive effects: dry mouth, blurred vision, constipation, urinary retention, confusion |
| Bronchospasm risk | Nebivolol + OAD/Pulmonary fibrosis | MODERATE | Even selective beta-1 blockers can precipitate bronchospasm in patients with obstructive airway disease. Nebivolol is relatively safer but still a concern at 5 mg dose. |
🟡 MODERATE INTERACTIONS
| Interaction | Drugs Involved | Risk |
|---|---|---|
| Domperidone + Levofloxacin | CINOD + Quinohike | Domperidone is the primary QT concern when combined with fluoroquinolones |
| Mirtazapine + Levofloxacin | Mirago + Quinohike | Mild additive QT risk - monitor ECG |
| Levosalbutamol-induced hypokalemia + QT drugs | Nebzmart + Levofloxacin + Domperidone | Beta-2 agonist drives K+ into cells → hypokalemia → further QT prolongation risk |
| Pantoprazole + Mirtazapine | Pantop + Mirago | Pantoprazole noted in some studies to contribute to QTc prolongation in combination with psychiatric drugs (see QT literature) |
SECTION 4: PRESCRIPTION RECONCILIATION
✅ Appropriate Prescribing
| Drug | Justification |
|---|---|
| Levofloxacin OD x 10 days | Appropriate for LRTI/AFI - covers atypical organisms |
| Pantoprazole 40 mg OD | GI protection justified with multiple drugs (antibiotic, NSAIDs if any, steroids if any) |
| Nebzmart (Levosalb + Ipatropium) TID | First-line bronchodilator combination for OAD - appropriate |
| Nebivolol 5 mg OD | Appropriate for HTN; metabolically safer beta-blocker |
| Zincovit | Appropriate for anemia + general weakness; nutritional support |
| Ambroxol (Pulmoclear) | Appropriate mucokinetic for LRTI + OAD |
| Mirtazapine 25 mg | Possibly for anorexia, sleep disturbance, generalized weakness - mirtazapine at low doses (7.5-15 mg) stimulates appetite and aids sleep. 25 mg is unusual (standard tabs: 7.5/15/30/45 mg) - verify dose |
⚠️ CONCERNS & FLAGS
| Issue | Detail | Recommendation |
|---|---|---|
| Duplicate mucolytics | Pulmoclear (Ambroxol) + Muconget (Acetylcysteine) both prescribed - both are mucolytics | Review necessity - one is usually sufficient. Keep Acetylcysteine (also antioxidant - beneficial in pulmonary fibrosis) |
| Duplicate listing of Zincovit | Listed twice (#2 as "Syp Zincovit 5ml BD" and #6 as "Syp Zincovit 5ml once") | Clarify - if both are same drug, this is a duplication error. Likely once daily is correct |
| Mirtazapine dose | 25 mg not a standard tablet size - standard formulations: 7.5 mg, 15 mg, 30 mg, 45 mg | Clarify intended dose - likely 15 mg or 30 mg |
| QT risk triad | Domperidone (CINOD) + Levofloxacin + Mirtazapine | Get baseline ECG if not done; monitor QTc; consider stopping CINOD while levofloxacin is ongoing |
| Nebivolol in OAD | Beta-blocker use in obstructive airway disease requires caution | Monitor for wheeze/bronchospasm; ensure lowest effective dose; it is prescribed for renovascular HTN and benefit likely outweighs risk at 5 mg |
| Anticholinergic load | Clidinium (Librax) + Ipratropium (Nebzmart) | Combined anticholinergic burden - watch for urinary retention, constipation, confusion especially in this 50-year-old female |
| Librax in AFI + LRTI | Benzodiazepine (Chlordiazepoxide) can cause respiratory depression | Use with caution; may be needed for anxiety/GI spasm but limit duration |
| STOPPED drugs - Minipress XL (Prazosin) | Correctly stopped - alpha-1 blocker. May have been stopped due to hypotension risk when combined with nebivolol (both BP lowering) or reflex tachycardia concern | Appropriate to stop given PR already 104/min |
| STOPPED - CINOD & Muconget | Noted with "STOP" on original sheet | If stopped on review, good - reduces QT risk and mucolytic duplication |
SECTION 5: OVERALL CLINICAL SUMMARY
Key Safety Concern: The most pressing pharmacological concern in this prescription is the triple QT-prolonging combination of Levofloxacin + Domperidone (CINOD) + Mirtazapine. Given that the patient has a resting tachycardia (PR 104), active infection, and is on a nebulized beta-2 agonist (which causes hypokalemia), her risk of drug-induced Torsades de Pointes is elevated.
Recommended Actions:
- Obtain a 12-lead ECG - check baseline QTc before continuing combination
- Stop or hold Domperidone while levofloxacin course is ongoing (10 days)
- Monitor serum potassium - levosalbutamol can drop K+, worsening QT risk
- Clarify Mirtazapine dose - 25 mg is not a standard tablet size
- Remove duplicate Zincovit listing
- Review need for two mucolytics - acetylcysteine alone is likely sufficient and beneficial in pulmonary fibrosis
- Monitor BP and HR daily - renovascular HTN with tachycardia needs tracking during antibiotic course
- Anticholinergic load monitoring - with both Clidinium and Ipratropium, watch for urinary retention and confusion
Disclaimer: This is a pharmacological analysis for educational/review purposes. All clinical decisions should be made by the treating physician with full patient history and examination.
Update tab minipress xl not stoped
Got it. Tab. Minipress XL (Prazosin) is NOT stopped - it is an active part of the prescription.
Here is the updated section with this correction applied throughout:
UPDATED DRUG LIST (Correction Applied)
| # | Drug (Brand) | Generic | Dose | Route | Frequency |
|---|---|---|---|---|---|
| 1 | Syp. Pulmoclear | Ambroxol + Guaifenesin | 5 ml | PO | BD |
| 2 | Syp. Zincovit | Zinc + Multivitamins | 5 ml | PO | OD |
| 3 | Syp. Muconget | Acetylcysteine | 10 ml | PO | BD |
| 4 | Tab. Pantoprazole | Pantoprazole | 40 mg | PO | OD |
| 5 | Tab. CINOD | Cinnarizine + Domperidone | 10 mg | PO | BD |
| 6 | Tab. Mirago | Mirtazapine | 25 mg | PO | OD |
| 7 | Tab. Librax | Chlordiazepoxide + Clidinium | 1 tab | PO | OD |
| 8 | Tab. Nebistar | Nebivolol | 5 mg | PO | OD |
| 9 | Tab. Minipress XL | Prazosin (extended release) | 5 mg | PO | OD ✅ ACTIVE |
| 10 | Neb. Nebzmart | Levosalbutamol + Ipratropium | 1 amp | Nebulization | TID |
| 11 | Tab. Quinohike | Levofloxacin | 500 mg | PO | OD x 10 days |
MOA of Tab. Minipress XL (Prazosin Extended Release)
Class: Selective alpha-1 adrenergic receptor blocker
MOA: Competitively blocks postsynaptic alpha-1 adrenoceptors in vascular smooth muscle → prevents norepinephrine-mediated vasoconstriction → reduces peripheral vascular resistance → lowers both systolic and diastolic BP. The XL (extended release) formulation provides smoother 24-hour blood pressure control and reduces first-dose hypotension. Also relaxes smooth muscle in the bladder neck and prostate (relevant in females too for urinary symptoms).
Indication here: Renovascular hypertension with BP 140/100 - used as add-on to Nebivolol.
Side Effects / ADRs:
- First-dose phenomenon: Sudden severe hypotension, syncope (especially with first dose or after dose increase)
- Postural/orthostatic hypotension - dizziness on standing
- Palpitations, reflex tachycardia
- Fluid retention, edema
- Headache, drowsiness
- Nasal congestion
UPDATED DDI - Additional Interaction with Minipress XL
🔴 NEW MAJOR CONCERN Added
| Interaction | Drugs | Risk | Detail |
|---|---|---|---|
| Hypotension (additive) | Minipress XL (Prazosin) + Nebivolol | HIGH | Both are antihypertensives. Prazosin (alpha-1 blocker) + Nebivolol (beta-1 blocker) combination = significant additive BP lowering. Risk of severe orthostatic hypotension and syncope, especially in a febrile, possibly dehydrated patient (AFI). |
| Reflex tachycardia worsened | Minipress XL alone | MODERATE | Alpha-1 blockade → vasodilation → baroreceptor reflex → tachycardia. Patient already has PR 104/min. Prazosin may worsen tachycardia. Nebivolol partially counteracts this (beta-blocker blunts reflex) but monitor HR carefully. |
| Hypotension + beta-2 agonist | Minipress XL + Levosalbutamol (Nebzmart) | MODERATE | Levosalbutamol causes vasodilation (beta-2 on vessels) + mild BP drop, which adds to prazosin-mediated hypotension |
UPDATED PRESCRIPTION RECONCILIATION FLAG
| Issue | Detail | Recommendation |
|---|---|---|
| Prazosin (Minipress XL) ACTIVE | Patient already has BP 140/100 + PR 104/min (tachycardia) + is febrile | Monitor BP closely - combination with Nebivolol risks over-lowering. Ensure patient is well hydrated. Advise against sudden standing (orthostatic precaution). |
| Dual antihypertensive therapy | Prazosin + Nebivolol | Rational combination (alpha + beta blockade) but requires close BP monitoring in an acutely ill febrile patient. Target BP should be 130/80 mmHg or lower per renovascular HTN guidelines. |
| Tachycardia concern | PR 104 with Prazosin on board | Alpha-1 blockade can worsen tachycardia. Nebivolol (beta-1 blockade) is the correct counterbalance. Ensure Nebivolol dose is adequate. |
Bottom line: With Minipress XL active, the patient is on dual antihypertensive therapy (alpha-blocker + beta-blocker). This is a rational combination for renovascular HTN, but in the setting of acute febrile illness, dehydration risk, and existing tachycardia, orthostatic hypotension and syncope are real risks. The QT triad (Levofloxacin + Domperidone + Mirtazapine) remains the top safety concern and should still be addressed with an ECG and potassium check.
Once again generate in one in short
PRESCRIPTION REVIEW - B. Vijay Laxmi | F | 50 yrs
Dx: AFI, LRTI, OAD, B/L Pulmonary Fibrosis | K/C/O: Renovascular HTN, Anemia
Vitals: Temp 99.6°F | BP 140/100 | PR 104/min | SpO2 97%
DRUGS + MOA + ADRs
| # | Drug | MOA | Key Side Effects |
|---|---|---|---|
| 1 | Syp. Pulmoclear (Ambroxol + Guaifenesin) 5ml BD | Stimulates surfactant, breaks mucus bonds, increases ciliary clearance; Guaifenesin hydrates mucus | Nausea, GI upset, rare allergic reaction |
| 2 | Syp. Zincovit (Zinc + Vitamins) 5ml OD | Cofactor for immunity + erythropoiesis; B12/folate for RBC maturation | GI upset on empty stomach |
| 3 | Syp. Muconget (Acetylcysteine) 10ml BD | Breaks disulfide bonds in mucus glycoproteins; antioxidant (glutathione precursor) | Nausea, stomatitis, bad odor |
| 4 | Tab. Pantoprazole 40mg OD | Irreversible H+/K+-ATPase inhibitor - blocks gastric acid secretion | Headache, diarrhea; long-term: hypomagnesemia, B12 deficiency |
| 5 | Tab. CINOD (Cinnarizine + Domperidone) 10mg BD | Cinnarizine: Ca2+ blocker + H1 blocker (anti-vertigo); Domperidone: D2 antagonist at CTZ (antiemetic, prokinetic) | Drowsiness; Domperidone: QT prolongation, hyperprolactinemia |
| 6 | Tab. Mirago (Mirtazapine) 25mg OD | NaSSA: blocks alpha-2 receptors → ↑NE + 5-HT release; blocks 5-HT2/5-HT3 + H1 → sedation + appetite stimulation | Weight gain, sedation, dry mouth; mild QT prolongation |
| 7 | Tab. Librax (Chlordiazepoxide 5mg + Clidinium 2.5mg) OD | Chlordiazepoxide: GABA-A positive modulator → anxiolytic; Clidinium: muscarinic antagonist → reduces GI spasm | Drowsiness, dry mouth, constipation, dependence risk |
| 8 | Tab. Nebistar (Nebivolol) 5mg OD | Beta-1 selective blocker + beta-3 → ↑NO → vasodilation; reduces HR + cardiac output | Fatigue, bradycardia, cold extremities; bronchospasm in OAD |
| 9 | Tab. Minipress XL (Prazosin ER) 5mg OD | Selective alpha-1 adrenoceptor blocker → vasodilation → ↓peripheral resistance → ↓BP | First-dose hypotension, orthostatic hypotension, palpitations, reflex tachycardia, edema |
| 10 | Neb. Nebzmart (Levosalbutamol + Ipratropium) 1amp TID | Levosalb: beta-2 agonist → ↑cAMP → bronchodilation; Ipratropium: M3 antagonist → blocks ACh bronchoconstriction | Tremor, tachycardia, hypokalemia (levosalb); dry mouth, urinary retention (ipatropium) |
| 11 | Tab. Quinohike (Levofloxacin) 500mg OD x 10d | Inhibits DNA gyrase + topoisomerase IV → bactericidal; covers atypicals (Mycoplasma, Legionella) | GI upset, insomnia; QT prolongation, tendon rupture, peripheral neuropathy |
DRUG-DRUG INTERACTIONS
| Severity | Pair | Risk |
|---|---|---|
| 🔴 Major | Levofloxacin + Domperidone + Mirtazapine | Triple QT prolongation → Torsades de Pointes risk. Patient has PR 104 + hypokalemia risk from Levosalbutamol - very high concern |
| 🔴 Major | Prazosin + Nebivolol | Additive hypotension + syncope risk, especially in febrile/dehydrated state |
| 🟡 Moderate | Mirtazapine + Chlordiazepoxide | Additive CNS + respiratory depression |
| 🟡 Moderate | Clidinium + Ipratropium | Additive anticholinergic burden → dry mouth, constipation, urinary retention, confusion |
| 🟡 Moderate | Nebivolol + OAD | Beta-blocker can worsen bronchospasm even if beta-1 selective |
| 🟡 Moderate | Prazosin + Levosalbutamol | Both vasodilatory → additive hypotension |
PRESCRIPTION RECONCILIATION
| Flag | Issue | Action |
|---|---|---|
| ⚠️ Duplicate mucolytic | Pulmoclear (Ambroxol) + Muconget (NAC) - both mucolytics | Keep one - prefer NAC (also antioxidant, beneficial in pulmonary fibrosis) |
| ⚠️ Duplicate Zincovit | Listed twice (BD and OD) | Clarify - OD is correct |
| ⚠️ Mirtazapine dose | 25 mg is not a standard tablet size (standard: 7.5/15/30/45 mg) | Verify - likely 15 mg intended |
| 🔴 QT triad active | Levofloxacin + Domperidone + Mirtazapine all on together | Get ECG; check serum K+; consider stopping Domperidone for 10-day antibiotic course |
| ⚠️ Tachycardia + Prazosin | PR 104 - alpha-1 blockade causes reflex tachycardia | Nebivolol counterbalances; monitor HR daily |
| ⚠️ Hypotension risk | Febrile patient on Prazosin + Nebivolol + Levosalbutamol | Ensure adequate hydration; advise slow position changes; monitor BP BD |
| ✅ Rational | Prazosin + Nebivolol (alpha + beta blockade) | Good combination for renovascular HTN if BP/HR monitored |
| ✅ Rational | Levofloxacin OD x 10d for LRTI | Appropriate spectrum + duration |
| ✅ Rational | Nebzmart TID for OAD | First-line bronchodilator therapy |
TOP 3 IMMEDIATE ACTIONS
- ECG now - check QTc before continuing Levofloxacin + Domperidone + Mirtazapine together
- Serum K+ - Levosalbutamol causes hypokalemia which worsens QT risk
- BP + HR monitoring BD - dual antihypertensive (Prazosin + Nebivolol) in febrile patient with PR 104 is a syncope/hypotension risk
This is a shared conversation. Sign in to Orris to start your own chat.